RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+17.22%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.6B
AUM Growth
+$2.6B
(+11%)
Cap. Flow
+$27.9M
Cap. Flow
% of AUM
1.07%
Top 10 Holdings %
Top 10 Hldgs %
27.05%
Holding
158
New
8
Increased
60
Reduced
23
Closed
11
Top Buys
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$21.9M |
| 2 |
UnitedHealth
UNH
|
$19.6M |
| 3 |
West Pharmaceutical
WST
|
$15.9M |
| 4 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$12.8M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$11.2M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$41.1M |
| 2 |
AET
Aetna Inc
AET
|
$40.4M |
| 3 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$23.5M |
| 4 |
Prothena Corp
PRTA
|
$11.7M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$9.97M |
Sector Composition
| 1 | Healthcare | 89.32% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UnitedHealth
UNH
$281B
| $139M | 5.36% | 567,500 +80,000 | +16% | +$19.6M |
|
2
Madrigal Pharmaceuticals
MDGL
$9.76B
| $95.7M | 3.68% | 342,300 +16,800 | +5% | +$4.7M |
|
3
Intuitive Surgical
ISRG
$170B
| $67.9M | 2.61% | 141,900 -2,000 | -1% | -$957K |
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $61.9M | 2.38% | 630,400 +24,200 | +4% | +$2.38M |
|
|
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $61.4M | 2.36% | 440,000 +80,000 | +22% | +$11.2M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $61.1M | 2.35% | 492,500 +7,500 | +2% | +$931K |
|
7
AbbVie
ABBV
$372B
| $55.6M | 2.14% | 600,000 | – | – |
|
|
WCG
8
DELISTED
Wellcare Health Plans, Inc.
WCG
| $54.9M | 2.11% | 223,000 +89,000 | +66% | +$21.9M |
|
9
Molina Healthcare
MOH
$9.8B
| $53.4M | 2.05% | 545,000 -31,000 | -5% | -$3.04M |
|
10
Acadia Healthcare
ACHC
$2.12B
| $51.3M | 1.97% | 1,253,500 | – | – |
|
|
LOXO
11
DELISTED
Loxo Oncology, Inc
LOXO
| $50.3M | 1.94% | 289,900 -26,600 | -8% | -$4.61M |
|
|
ONCE
12
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $45M | 1.73% | 544,000 -79,500 | -13% | -$6.58M |
|
13
HCA Healthcare
HCA
$94.5B
| $44.1M | 1.7% | 430,000 +50,000 | +13% | +$5.13M |
|
14
Collegium Pharmaceutical
COLL
$1.22B
| $39.4M | 1.51% | 1,650,000 -270,000 | -14% | -$6.44M |
|
15
Sarepta Therapeutics
SRPT
$1.78B
| $39.3M | 1.51% | 297,500 +39,500 | +15% | +$5.22M |
|
16
iRhythm Technologies
IRTC
$5.46B
| $38.9M | 1.5% | 480,000 +2,500 | +0.5% | +$203K |
|
17
Pacira BioSciences
PCRX
$1.2B
| $38.4M | 1.48% | 1,198,000 +73,000 | +6% | +$2.34M |
|
|
RDUS
18
DELISTED
Radius Health, Inc.
RDUS
| $33.2M | 1.28% | 1,125,000 +125,000 | +13% | +$3.68M |
|
|
ONC
19
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $33.1M | 1.27% | 215,000 -6,250 | -3% | -$961K |
|
20
Penumbra
PEN
$10.6B
| $32.7M | 1.26% | 236,750 -6,250 | -3% | -$863K |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $32.4M | 1.25% | 190,500 +9,500 | +5% | +$1.61M |
|
22
Encompass Health
EHC
$12.3B
| $30.5M | 1.17% | 450,000 +123,000 | +38% | +$8.33M |
|
23
Stryker
SYK
$150B
| $30.1M | 1.16% | 178,000 | – | – |
|
|
CELG
24
DELISTED
Celgene Corp
CELG
| $28.6M | 1.1% | 360,400 +50,300 | +16% | +$3.99M |
|
25
DaVita
DVA
$9.85B
| $28.4M | 1.09% | 408,500 +1,000 | +0.2% | +$69.4K |
|